Medical imaging

Harvard MedTech to Discuss New Approaches to Pain Management for Injured Workers During Panel Presentation at Worker’s Compensation Institute Conference

Tuesday, November 30, 2021 - 7:31pm

Harvard MedTech, a breakthrough digital health company, will participate in a panel presentation highlighting new approaches to pain management, including virtual reality technology and spinal cord stimulation, at the Workers Compensation Institute conference in Orlando, Florida, on Tuesday, Dec. 14, 2021, at 1:00 PM.

Key Points: 
  • Harvard MedTech, a breakthrough digital health company, will participate in a panel presentation highlighting new approaches to pain management, including virtual reality technology and spinal cord stimulation, at the Workers Compensation Institute conference in Orlando, Florida, on Tuesday, Dec. 14, 2021, at 1:00 PM.
  • Panelists will discuss two novel therapies that offer solutions for injured workers suffering with chronic pain that remove the risks associated with opioids: spinal cord stimulation and virtual reality.
  • He will also outline best practices and present case studies that demonstrate the program can be a successful alternative to opioids for managing pain.
  • I look forward to sharing how Harvard MedTechs Vx Therapy takes a holistic approach to pain management, combining the biopsychosocial model with virtual reality therapy.

metaMe Health Receives FDA Clearance for Regulora®, the First FDA-authorized Treatment Specifically for Abdominal Pain Due to Irritable Bowel Syndrome (IBS)

Tuesday, November 30, 2021 - 7:30pm

Treatment of abdominal pain associated with IBS is poised for a fundamental shift in clinical practice.

Key Points: 
  • Treatment of abdominal pain associated with IBS is poised for a fundamental shift in clinical practice.
  • "The FDA's clearance of Regulora, our first PDT, is a major achievement for the company," said Tim Rudolphi, CEO of metaMe Health.
  • Irritable Bowel Syndrome is a chronic condition of the lower gastrointestinal tract that affects 10-15% of adults in the United States.
  • PDTs are developed under rigorous conditions complete with clinical trials, FDA clearance, and availability only through a physician's prescription.

AWS Announces AWS IoT TwinMaker

Tuesday, November 30, 2021 - 6:38pm

There are no up-front commitments or fees to use AWS IoT TwinMaker, and customers only pay for the AWS services used.

Key Points: 
  • There are no up-front commitments or fees to use AWS IoT TwinMaker, and customers only pay for the AWS services used.
  • Using AWS IoT TwinMaker, developers can quickly get started building digital twins of devices, equipment, and processes by connecting AWS IoT TwinMaker to data sources like equipment sensors, video feeds, and business applications.
  • We are excited to work with AWS and expand connections between our Xcelerator portfolio and AWS services including the new AWS IoT TwinMaker service.
  • Through the Accenture AWS Business Group, we have been able to start leveraging AWS IoT TwinMaker and we are excited for the value it can bring our customers.

Global PACS and RIS Market to grow US$ 5,169.3 Mn by end of 2028, Says Coherent Market Insights

Tuesday, November 30, 2021 - 6:30pm

The advent of innovative PACS and RIS products is driving the growth of the market.

Key Points: 
  • The advent of innovative PACS and RIS products is driving the growth of the market.
  • An increasing number of hospitals and rapid adoption of PACS and RIS in hospitals is accelerating growth of the market.
  • Growing adoption of digital pathology is expected to provide lucrative growth opportunities to PACS and RIS market .
  • Global PACS and RIS Market, By Product Type:
    Global PACS and RIS Market, By Component:

Global PACS and RIS Market to grow US$ 5,169.3 Mn by end of 2028, Says Coherent Market Insights

Tuesday, November 30, 2021 - 6:30pm

The advent of innovative PACS and RIS products is driving the growth of the market.

Key Points: 
  • The advent of innovative PACS and RIS products is driving the growth of the market.
  • An increasing number of hospitals and rapid adoption of PACS and RIS in hospitals is accelerating growth of the market.
  • Growing adoption of digital pathology is expected to provide lucrative growth opportunities to PACS and RIS market .
  • Global PACS and RIS Market, By Product Type:
    Global PACS and RIS Market, By Component:

Fragmented CDS Tech Poses Problems for Healthcare Data Interoperability

Tuesday, November 30, 2021 - 6:10pm

(1) Now, according to recent estimates, up to 74 percent of healthcare provider organizations use clinical decision support (CDS) technology.

Key Points: 
  • (1) Now, according to recent estimates, up to 74 percent of healthcare provider organizations use clinical decision support (CDS) technology.
  • Fragmentation of CDS systems in a virtual/remote care environment is a problem faced by healthcare entities across the nation.
  • Beyond the problem of integration between CDS systems themselves, many also don't easily incorporate into a healthcare entity's existing electronic health records (EHR).
  • Today, about 55 percent of healthcare provider organizations use multiple CDS systems for their current brick and mortar implementations.

Metaverse Leader ImmersiveTouch Wins FDA Clearance For New Suite of Medical Diagnosis and Treatment Planning Tools

Tuesday, November 30, 2021 - 5:12pm

Giving surgeons the capability to diagnose and treat patients virtually will reduce planning hours and increase efficiency which is crucial for both physicians and patients.

Key Points: 
  • Giving surgeons the capability to diagnose and treat patients virtually will reduce planning hours and increase efficiency which is crucial for both physicians and patients.
  • The segmented 3D models can be utilized for medical diagnosis, anatomical measuring, treatment planning, and generating output files for additive manufacturing.
  • ImmersiveTouch empowers clinicians with greater precision and consistency of care using technology to simulate each patients unique pathology in 3D through its immersive VR metaverse.
  • The companys proprietary platform integrates solutions for surgical planning, training, and patient engagement.

Spect Launches to Build Largest Retinal Data Set in the World and Diagnose Critical Health Conditions, Starting with Diabetes

Tuesday, November 30, 2021 - 5:00pm

Retinal screening can prevent diabetic retinopathy, and give early warnings about heart attack, stroke, Alzheimer's, and Parkinson's.

Key Points: 
  • Retinal screening can prevent diabetic retinopathy, and give early warnings about heart attack, stroke, Alzheimer's, and Parkinson's.
  • Sadly, despite this, people skip their annual eye screenings because it's costly and inconvenient," said Mike Ricci, CEO and Co-Founder of Spect.
  • Spect solves today's retinal exam pain points so that millions of patients can, and will, get the preventative care they need."
  • Spect brings eye care to primary care, benefitting:
    Patients: Spect improves patient health by making it easy to receive vital eye screenings.

Canon Medical and Resoundant, Inc. Partnership to Provide Magnetic Resonance Elastography on Canon MRI Scanners

Tuesday, November 30, 2021 - 5:00pm

Canon Medical Systems Corporation and Resoundant, Inc. (Rochester, MN, USA) have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms.

Key Points: 
  • Canon Medical Systems Corporation and Resoundant, Inc. (Rochester, MN, USA) have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms.
  • Canon Medical and Resoundant have been working closely together to implement a seamless integration of the latest MRE technology on Canons newest line of MRI scanners.
  • MR Elastography was invented at Mayo Clinic and is the only MRI technology that has been validated for staging liver fibrosis.
  • Resoundant, Inc. is a medical technology company dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance Elastography (MRE) available around the world.

Global Ultrasonic Electrosurgical Devices (Consumables, Generators) Market Analysis & Forecasts, 2017-2020 & 2021-2028 - ResearchAndMarkets.com

Tuesday, November 30, 2021 - 4:25pm

The global ultrasonic electrosurgical devices market size is expected to reach USD 5.45 billion by 2028 and is expected to expand at a CAGR of 5.04% from 2021 to 2028.

Key Points: 
  • The global ultrasonic electrosurgical devices market size is expected to reach USD 5.45 billion by 2028 and is expected to expand at a CAGR of 5.04% from 2021 to 2028.
  • Furthermore, the increasing incidence of cancer across the globe is predicted to boost the demand for ultrasonic electrosurgical devices.
  • Several manufacturers are focusing on developing technologically advanced ultrasonic electrosurgical devices to maintain a strong market presence.
  • Ultrasonic Electrosurgical Devices Market Variables, Trends & Scope